Issue 24, 2025, Issue in Progress
From the journal:

RSC Advances

Retraction: Design and synthesis of VEGFR-2 tyrosine kinase inhibitors as potential anticancer agents by virtual based screening

Harun M. Patel,ab   Pankaj Bari,b   Rajshekhar Karpoormath,a   Malleshappa Noolvi,c   Neeta Thapliyal,a   Sanjay Suranab  and  Pritam Jain*b  

* Corresponding authors

a Dept. of Pharmaceutical Chemistry, University of KwaZulu-Natal (Westville Campus), Private Bag X54001, Durban-4000, South Africa

b Department of Pharmaceutical Chemistry, R.C. Patel College of Pharmacy, Shirpur, Dhule 425405, Maharashtra, India
E-mail: pritash79@yahoo.com
Fax: +91-2563-251808
Tel: +91-2563-255189

c Department of Pharmaceutical Chemistry, Shree Dhanvantary Pharmacy College, Kim, Surat-3941110, Gujarat, India

Abstract

Retraction of ‘Design and synthesis of VEGFR-2 tyrosine kinase inhibitors as potential anticancer agents by virtual based screening’ by Harun M. Patel et al., RSC Adv., 2015, 5, 56724–56771, https://doi.org/10.1039/C5RA05277G.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D5RA90070K
Article type
Retraction
Submitted
28 May 2025
Accepted
28 May 2025
First published
04 Jun 2025
This article is Open Access
Creative Commons BY license

RSC Adv., 2025,15, 18814-18814

Permissions

Request permissions

Retraction: Design and synthesis of VEGFR-2 tyrosine kinase inhibitors as potential anticancer agents by virtual based screening

H. M. Patel, P. Bari, R. Karpoormath, M. Noolvi, N. Thapliyal, S. Surana and P. Jain, RSC Adv., 2025, 15, 18814 DOI: 10.1039/D5RA90070K

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements